Rociletinib

Rociletinib is an orally available small molecule, irreversible inhibitor of epidermal growth factor receptor (EGFR) with potential antineoplastic activity.

Price Not Available 25 mg Rociletinib Supplier Page

Catalog Number	T2369
Alternative Name(s)	AVL-301 , CNX-419 , CO-1686
Research Area	Angiogenesis\|\|\|Tyrosine Kinase/Adaptors\|\|\|JAK/STAT signaling
Molecular Formula	C27H28F3N7O3
CAS#	1374640-70-6
SMILES	COc1c(Nc2ncc(c(Nc3cc(NC(=O)C=C)ccc3)n2)C(F)(F)F)ccc(c1)N1CCN(CC1)C(=O)C
Size	25 mg
Supplier Page	https://www.targetmol.com/compound/Rociletinib
Additional Information	https://www.targetmol.com/datasheet/T2369